← Evidence map

ArticlemAbs

A TRAILR2/CDH3 bispecific antibody demonstrates selective apoptosis and tumor regression in CDH3-positive pancreatic cancer.

Peter Jung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2025
2026
cites it
Full record →Abstract, authors, funding and every citing paper · PMID 39654063